Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
Redlich
Kurt
K
University of Vienna, Vienna, Austria.
Schett
Georg
G
Steiner
Günter
G
Hayer
Silvia
S
Wagner
Erwin F
EF
Smolen
Josef S
JS
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha